Clinical Trials Browser

INDUSTRY × Hematologic Neoplasms × WW Domain-Containing Oxidoreductase × Clear all

NCT01949545 2017-05-02

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Phase 1 Completed

46 enrolled 45 charts

Other hematologic neoplasm

Hematologic Neoplasms